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Rab9 plays a vital role in regulating the transport of
mannose 6-phosphate receptors from late endo-
somes to the trans-Golgi network through inter-
actions with various effectors. Here, we report the
crystal structure of GTP-bound Rab9A in complex
with the Rab-binding domain (RBD) of the effector
RUTBC2. RUTBC2RBDassumes a pleckstrin homol-
ogy domain fold that uses a binding site consisting of
mainly b1 and the h1 insertion to interact with the
switch and interswitch regions of Rab9A. The C-ter-
minal hypervariable region of Rab9A is disordered
and thus not required for RUTBC2 binding. The
conformational plasticity of the switch and inter-
switch regions of Rab9A primarily determines the
specificity for RUTBC2. Our biochemical and biolog-
ical data confirm these findings and further show that
Rab9B can bind to RUTBC2 probably in a similar
manner as Rab9A. These results together reveal the
molecular basis for the binding specificity of Rab9A
with RUTBC2.
INTRODUCTION
RabGTPases comprise70members and constitute the largest
family of small GTPases (Barr and Lambright, 2010; Zerial and
McBride, 2001). Rabs localize to distinct organelle membranes
and function together with their effectors to play central roles
in regulating the vesicle-mediated transport including vesicle
budding, transport, tethering, and fusion in eukaryotic organisms
(Bonifacino and Glick, 2004; Grosshans et al., 2006; Stenmark,
2009). Like other small GTPases, Rabs cycle between two
states, the GTP-bound active state and the GDP-bound inactive
state, and the conversions are assisted by guanine exchange
factors (GEFs) and GTPase-activating proteins (GAPs). The
active Rabs can bind a variety of effectors that can recruit motor
proteins or serve as cargo adaptors and tethering factors to facil-
itate membrane trafficking.
Different Rabs can bind their specific effectors and then
execute distinct functions in certain types or different steps of1408 Structure 22, 1408–1420, October 7, 2014 ª2014 Elsevier Ltd Amembrane trafficking (Barr and Lambright, 2010). Rabs
commonly use the switch and interswitch regions to bind the ef-
fectors, such as in the Rab4/Rab22-Rabenosyn-5 (Eathiraj et al.,
2005), Rab5-Rabaptin-5 (Zhu et al., 2004), Rab6-Rab6IP1 (Reca-
cha et al., 2009), and Rab11-FIP2/FIP3 (Eathiraj et al., 2006; Ja-
goe et al., 2006; Shiba et al., 2006) complexes. This binding
mode is mediated predominantly by a hydrophobic surface
formed by the switch and interswitch regions including a hydro-
phobic triad of three conserved aromatic residues and a hydro-
phobic patch formed by three variable hydrophobic residues
(Itzen and Goody, 2011; Merithew et al., 2001). In some cases,
like in the Rab3-Rabphilin-3A (Ostermeier and Brunger, 1999),
Rab7-RILP (Wu et al., 2005), and Rab27-Slp2-a/Slac2-a (Chavas
et al., 2008; Kukimoto-Niino et al., 2008) complexes, in addition
to the switch and interswitch regions, the so-called complemen-
tarity-determining regions (CDRs), which comprise the N and C
termini and the a3–b5 loop and exhibit high sequence variation
(Ostermeier and Brunger, 1999; Pereira-Leal and Seabra,
2000), are also involved in determining the binding specificity
of Rabs for the effectors. Although the effectors have unrelated
sequences and structural folds, their binding with Rabs can be
divided into all-a-helical, mixed a-helical, b-b zipping, and biva-
lent modes (Khan and Me´ne´trey, 2013).
Rab9 is predominantly bound to late endosome membranes
and is required for the transport of mannose 6-phosphate recep-
tors (MPRs) from late endosomes to the trans-Golgi network
(TGN) (Barbero et al., 2002; Lombardi et al., 1993). In addition,
Rab9 can function in lysosome biogenesis and late endosome
morphology (Ganley et al., 2004; Riederer et al., 1994). It can
also act as a cellular target for some pathogens, such as HIV
and Salmonella, and plays an important role in the pathogenic
infection (McGourty et al., 2012; Murray et al., 2005). So far,
several Rab9 effectors have been identified including p40,
Tip47, GCC185, and RhoBTB3, all of which are involved in the
recycling of MPRs. Tip47 and p40 are localized to the late endo-
some membranes and are involved in the cargo sorting of MPRs
to the Rab9-bound late endosomal recycling vesicles (Carroll
et al., 2001; Dı´az et al., 1997; Hanna et al., 2002). GCC185 and
RhoBTB3 are present on the TGN and function in the membrane
fusion of the Rab9-bound vesicles and the TGN (Espinosa et al.,
2009; Reddy et al., 2006). Moreover, HPS1-HPS4 of the BLOC-3
complex is shown to be a Rab9 effector, and thus Rab9 may
regulate BLOC-3 function in the biogenesis of lysosome-related
organelles (Kloer et al., 2010).ll rights reserved
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Structural Basis of the Rab9A-RUTBC2 InteractionRab9 has two isoforms, namely Rab9A and Rab9B. Recently,
two Rab9A effectors, namely RUTBC1 and RUTBC2 (also called
SGSM2 and SGSM1), were identified, which are conserved
in many eukaryotic organisms (Nottingham et al., 2011, 2012).
Human RUTBC1 is expressed ubiquitously in various tissues
and RUTBC2 mainly in brain, heart, and testis, whereas mouse
RUTBC1 and RUTBC2 are expressed in the neurons of central
nervous system (Yang et al., 2007). RUTBC1 and RUTBC2
contain an N-terminal RPIP8/Unc-14/NESCA (RUN) domain
and a C-terminal Tre-2/Bub2/Cdc16 (TBC) domain. RUN domain
usually functions as protein-protein interaction domain and can
act as effectors of some Rap and Rab GTPases (Callebaut
et al., 2001), whereas TBC domain can display GAP activity to-
ward some Rabs (Fukuda, 2011). The TBC domains of RUTBC1
and RUTBC2 exhibit GAP activity toward Rab32/Rab33B and
Rab34/Rab36, respectively (Nottingham et al., 2011, 2012), but
the exact function(s) of the RUN domains of RUTBC1 and
RUTBC2 are yet unknown. The intermediate region between
the RUN and TBC domains contains the binding site for both
Rab9A and Rap (Nottingham et al., 2011, 2012; Yang et al.,
2007).
The crystal structures of Rab9 bound with GDP or GppNHp
(50-guanylyl imidodiphosphate, a nonhydrolyzable GTP analog)
have been determined previously and show a classical nucleo-
tide binding fold similar to other small GTPases (Chen et al.,
2004; Eathiraj et al., 2005; Wittmann and Rudolph, 2004). So
far, although many Rab9 effectors have been identified, no
structural information about any Rab9-effector complex has
been reported, and thus the molecular basis for the binding
specificity of Rab9 with its effectors is unknown. Here, we
report the crystal structure of the GTP-bound Rab9A in com-
plex with the Rab-binding domain (RBD) of RUTBC2. RUTBC2
RBD adopts a pleckstrin homology (PH) domain fold and uses a
binding site consisting of mainly b1 and the h1 insertion via a
‘‘mixed a/b’’ mode to bind Rab9A. The C-terminal hypervari-
able region of Rab9A is disordered in this complex structure
and thus is not required for RUTBC2 binding. The conforma-
tional plasticity of the switch and interswitch regions of
Rab9A primarily determines the specificity for RUTBC2. Our
biochemical and biological data confirm these findings and
further show that Rab9B can also bind to RUTBC2 probably
in a similar manner as Rab9A. These data together reveal the
molecular basis for the binding specificity of Rab9A with
RUTBC2.
RESULTS
Crystal Structure of the Rab9A-RUTBC2 RBD Complex
It was reported previously that the Rab-binding domain (RBD) of
RUTBC1/RUTBC2 lies in the intermediate region (residues 188–
450) between the RUN and TBC domains (Nottingham et al.,
2011, 2012) (Figure 1A). To narrow down the exact binding
domain of RUTBC2 required for Rab9A binding, we constructed
a series of truncation forms of mouse RUTBC2 and tested
their binding abilities with mouse Rab9A by GST pull-down
assay. The results showed that a minimal fragment of RUTBC2
(residues 254–425) could form a stable complex with the GTP-
bound constitutively active Rab9A Q66L mutant (residues 1–
199). This complex could be purified in the presence of GTPStructure 22, 1408–and Mg2+ with high stability and homogeneity and be crystal-
lized in space group P212121. The crystal structure of the
Rab9A-RUTBC2 RBD complex was solved at 2.30 A˚ resolution
and the asymmetric unit contains one complex (Figures 1B and
S1A; Table 1). Residues 6–177 of Rab9A are well defined and
the C-terminal hypervariable region (residues 178–199) is disor-
dered. The bound GTP and Mg2+ at the active site are also
clearly defined. Residues 254–424 of RUTBC2 RBD are well
defined except for the loop before the last b strand (residues
390–413).
The structure of RUTBC2 RBD is composed mainly of seven b
strands forming two b sheets (b1–b4, and b5–b6 and b8, respec-
tively) and an abutting a helix (a1) sandwiched by the b sheets. In
addition, one short b strand (b7) and five 310 helices (h1–h5) are
scattered in the connecting loops (Figures 1B and S1B). A struc-
tural similarity search using the DALI server (Holm and Rose-
nstro¨m, 2010) reveals that the core structure of the RBD adopts
a pleckstrin homology (PH) domain foldwith the highest similarity
to the GRAM domain of MTMR2 (a Z score of 9.3 and a root-
mean-square deviation [rmsd] of 2.0 A˚ for 88 Ca atoms) (Begley
et al., 2003) and Exo84 (a Z score of 8.7 and an rmsd of 2.4 A˚ for
86 Ca atoms) (Jin et al., 2005) (Figure 1C) despite of their very low
sequence similarities (12%). Nevertheless, there are great var-
iations in both sequence and length of the loop regions that
appear to supplement the b sandwich core to render diverse
binding sites for protein partners (Figure S1C). For example,
RUTBC2 RBD contains a relatively long insertion in the b3–b4
loop that forms three 310 helices (h1–h3) and is involved in the
interaction of Rab9A (see results later). It is also noteworthy
that in RUTBC2 RBD, the region corresponding to b7 of the
three-stranded b sheet in the canonical PH domains assumes
a loop conformation, and instead, the C-terminal region forms
an extra b strand (b8) to make the three-stranded b sheet with
b5 and b6 (Figure 1C).
In the Rab9A-RUTBC2 RBD complex, the overall structure of
the GTP-bound Rab9A is very similar to that of the GppNHp-
bound Rab9A (an rmsd of 0.67 A˚ for 170 Ca atoms) (Eathiraj
et al., 2005) as well as the GDP-bound Rab9A (an rmsd of
0.87 A˚ for 170 Ca atoms) (Chen et al., 2004) (Figure 1D). How-
ever, the switch and interswitch regions assume the active
conformation similar to that in the GppNHp-bound Rab9A but
different from that in the GDP-bound Rab9A. There are only a
few residues in the switch regions exhibiting notable conforma-
tional differences from these in the GppNHp-bound Rab9A,
including Phe37, Glu43, and Arg68 of Rab9A, which are all
involved in either hydrophobic or hydrophilic interactions with
RUTBC2 RBD (Figure 1D).
Interactions between Rab9A and RUTBC2 RBD
The interactions between Rab9A and RUTBC2 RBD involve
switch I, switch II, and a small part of the interswitch region of
Rab9A, and b1, b2, and h1 of RUTBC2 RBD (Figures 1B, 2A,
and 2B). The CDRs of Rab9A including the C-terminal hypervar-
iable region are not involved in the interactions (Figures 1B and
2C). At the interaction interface, Rab9A and RUTBC2 RBD
show good complementarities in both geometrical and electro-
static properties (Figure 2D). The interaction interface buries a
total solvent accessible surface area of 1,292 A˚2 and consists
of two hydrophobic patches and a hydrophilic patch. At one1420, October 7, 2014 ª2014 Elsevier Ltd All rights reserved 1409
Figure 1. Crystal Structure of the Rab9A-
RUTBC2 RBD Complex
(A) A schematic diagram showing the domain or-
ganizations of RUTBC2.
(B) A ribbon representation of the overall structure
of the Rab9A-RUTBC2 RBD complex. The switch
I, interswitch, switch II, and CDRs of Rab9A are
colored in magenta, yellow, cyan, and orange,
respectively, and the rest of Rab9A is colored in
gray. The bound GTP and Mg2+ are shown with a
stick model and a red sphere, respectively.
RUTBC2 RBD is shown in green and the residues
participating in interactions with Rab9A are high-
lighted in red. Rab9A and RUTBC2 RBD are
labeled with secondary structures. The C-terminal
hypervariable domain (residues 178–199) of
Rab9A and the loop between h5 and b8 (residues
390–413) of RUTBC2 RBD are disordered. The
disordered loop in RUTBC2 RBD is shown with a
dotted line.
(C) Structural comparison of RUTBC2 RBD
(green), the GRAM domain of MTMR2 (salmon,
PDB code 1LW3) (Begley et al., 2003), and Exo84
(yellow, PDB code 1ZC3) (Jin et al., 2005). These
PH domains are shown in similar orientations.
(D) Structural comparison of Rab9A/Rab9B in
different nucleotide-bound forms. TheGTP-bound
Rab9A in the Rab9A-RUTBC2 RBD complex is
colored in yellow, the GppNHp-bound Rab9A
(PDB code 1YZL) (Eathiraj et al., 2005) in pink, the
GDP-bound Rab9A (PDB code 1WMS) (Chen
et al., 2004) in gray, and the GppNHp-bound
Rab9B (PDB code 2OCB) in cyan. The zoom-in
panel shows a detailed comparison of the switch
and interswitch regions. The residues exhibiting
notable conformational differences are under-
lined.
See also Figures S1, S5, and S6.
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Structural Basis of the Rab9A-RUTBC2 Interactionhydrophobic patch, the conserved hydrophobic triad (Phe44,
Trp61, and Phe76) of Rab9A surround Leu256 in b1 of RUTBC2
RBD, making compact hydrophobic interactions (Figures 2A and
2B). At the other hydrophobic patch, Phe37 and Ile40 in switch I
and Phe69 and Leu72 in switch II of Rab9A make extensive hy-
drophobic interactions with Asn262 in b1 and Asn294 and
Met297 in h1 of RUTBC2 RBD (Figures 2A and 2B). In between
the two hydrophobic patches, the conserved ‘‘IGVEF’’ motif of
switch I forms a hydrophilic patch to interact with several polar
residues of RUTBC2 RBD (Figures 2A and 2B). Specifically, the1410 Structure 22, 1408–1420, October 7, 2014 ª2014 Elsevier Ltd All rights reservedmain-chain amino of Ile40 and the amino
and carbonyl of Gly41 form three hy-
drogen bonds with the side chain of
Asn261 in b1 of RUTBC2 RBD; the
main-chain carbonyl of Val42 forms a
hydrogen bond with the side chain of
Tyr277 in b2 of RUTBC2 RBD; and the
side chain of Glu43 forms a hydrogen
bond with the side chain of Asn261 and
a salt bridge with the side chain of
Lys260 in b1 of RUTBC2 RBD. At the pe-
ripheral sides, the main-chain carbonyl of
Phe44 in the interswitch and the sidechain of Arg68 in switch II each form a hydrogen bond with the
side chain of Gln361 in a1 and the main-chain carbonyl of
Asn298 in h1 of RUTBC2 RBD, respectively.
Mutational Analyses of the Rab9A-RUTBC2
RBD Interaction
To verify the biological relevance of the Rab9A-RUTBC2 RBD
complex in vitro, we first mutated the key residues of both
Rab9A Q66L (residues 1–199) and RUTBC2 RBD (residues
254–425) at the interaction interface to Ala and tested their
Table 1. Summary of Diffraction Data and Structure Refinement
Statistics
Rab9A-RUTBC2 RBD
Diffraction Data
Wavelength (A˚) 0.9789
Space group P212121
Cell parameters
a (A˚) 52.8
b (A˚) 60.0
c (A˚) 127.8
a = b = g () 90.0
Resolution (A˚) 50.00–2.30 (2.38–2.30)a
Observed reflections 107,241
Unique reflections (I/s(I) > 0) 18,655
Average redundancy 5.7 (6.0)
Average I/s(I) 19.6 (4.7)
Completeness (%) 98.7 (100.0)
Rmerge (%)
b 7.9 (35.4)
Refinement and Structure Model
Reflections (FoR 0s(Fo))
Working set 17,468
Test set 961
Rwork/Rfree (%)
c 18.1/23.3
No. of atoms 2,696
Protein 2,559
GTP 32
Mg2+ 1
Water 104
Average B factor (A˚2)
All atoms 56.3
Main-chain atoms 53.2
Side-chain atoms 60.4
GTP 33.6
Mg2+ 36.0
Water 51.7
Rmsd
Bond lengths (A˚) 0.009
Bond angles () 1.2
Ramachandran plot (%)
Most favored 91.7
Allowed 7.9
Generously allowed 0.4
aNumbers in parentheses represent the highest resolution shell.
bRmerge =
P
hkl
P
ijIi(hkl)i  <I(hkl)>j/
P
hkl
P
iIi(hkl).
cR =
P
hkljjFoj  jFcjj/
P
hkljFoj.
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Structural Basis of the Rab9A-RUTBC2 Interactioneffects on the Rab9A-RUTBC2 RBD interaction by both GST
pull-down assay and isothermal titration calorimetry (ITC) anal-
ysis. Our biochemical results show that these mutations have
no effects on the solubility and stability of the proteins (data
not shown). In addition, our high-performance liquid chromatog-
raphy (HPLC) analysis results show that the mutations of Rab9A
do not affect the GTP binding (data not shown). However, ourStructure 22, 1408–GST pull-down and ITC analysis results show that these muta-
tions impair the Rab9A-RUTBC2 RBD interaction to varying de-
grees (Figures 3A, 3B, S2A, and S2B; Table 2). On the Rab9A
side, mutations I40A, V42A, F44A, W61A, F69A, L72A, and
F76A decrease the binding ability of Rab9A to RUTBC2 RBD
by >50% as shown by the GST pull-down results and increase
their dissociation constants (Kd) by 30- to 100-fold as shown
by the ITC results, suggesting that these hydrophobic contacts
play an important role in the interaction. Intriguingly, mutation
F37A has insignificant effect on the interaction (Figures 3A, 3B,
and S2A; Table 2), consistent with the observation that this res-
idue is highly varied among different Rab GTPases and thus
might play a less critical role in the binding of the effector (Fig-
ure 2C). Mutation of Gly41 to either Ala or Asp dramatically im-
pairs the binding ability by >70% and consistently thesemutants
have no measurable Kd probably due to their potential steric
conflicts with RUTBC2 RBD.Mutation E43A diminishes the bind-
ing ability to <15% and significantly increases the Kd by 230-
fold as this mutation disrupts the hydrogen-bonding and salt
bridge interactions with RUTBC2 RBD in the hydrophilic core,
suggesting that these hydrophilic interactions also play a critical
role in the Rab9A-RUTBC2 RBD interaction. In contrast, the
R68A mutant retains 80% of the binding ability and the Kd is
increased only by 8-fold as this residue is located at one pe-
ripheral edge and its mutation does not affect the core interac-
tions. On the RUTBC2 RBD side, mutations L256A, K260A,
N261A, Y277A, N294A, and M297A severely abolish its binding
with Rab9A and these mutants have either dramatically
increased Kd (70- to 140-fold, L256A, K260A, and M297A) or
nomeasurable Kd (N261A, Y277A, and N294A) as these residues
participate in the extensive hydrophobic and hydrophilic interac-
tions (Figures 3A, 3B, S2A, and S2B; Table 2). However, muta-
tions of Asn262 (that has few hydrophobic contacts) and
Gln361 (that forms a hydrogen bond with Phe44 of Rab9A at
the other peripheral edge) to Ala have less significant effects
on the Rab9A binding as shown by both GST pull-down results
and ITC results. These results support the structural data very
well.
To verify the functional role of the Rab9A-RUTBC2 interac-
tion in vivo, we cotransfected the wild-type and several mu-
tants of full-length Rab9A (WT, I40A, G41A, F44A, and I40A/
G41D/F44A) and full-length RUTBC2 (WT, L256A, N261A,
Y277A, and L256A/N261A/Y277A) into HeLa cells and
analyzed the localization patterns of the two proteins (Figures
3C and S2C). In the cells cotransfected with the wild-type
Rab9A and RUTBC2, most of Rab9A localize to the vesicle
membranes with a relatively concentrated distribution pattern,
and some of RUTBC2 are recruited to the Rab9A-positive
membranes and colocalize well with Rab9A although most of
RUTBC2 diffuse in the cytoplasm. However, in the cells co-
transfected with either or both of the Rab9A and RUTBC2 mu-
tants (either single mutation or triple mutation), RUTBC2 is
diffusely distributed in the cytoplasm and cannot localize to
the Rab9A-posivie vesicles as these mutations disrupt the
Rab9A-RUTBC2 RBD interaction, consistent with our in vitro
GST pull-down and ITC results. These functional analysis re-
sults together indicate that the Rab9A-RUTBC2 RBD interac-
tion is biologically relevant and is essential for the membrane
localization of RUTBC2.1420, October 7, 2014 ª2014 Elsevier Ltd All rights reserved 1411
Figure 2. Interactions between Rab9A and
RUTBC2 RBD
(A) A ribbon representation of the interaction
interface between Rab9A and RUTBC2 RBD. The
color scheme is the same as that in Figure 1B. The
interacting residues are shown with side chains
and the hydrophilic interactions are indicated with
dotted lines. The interface can be divided into
three patches including two hydrophobic patches
(boxed by solid lines in gray and black, respec-
tively) and a hydrophilic patch in between (boxed
by dotted lines).
(B) A schematic diagram showing the interactions
between Rab9A and RUTBC2 RBD. The color
scheme is the same as that in (A). The interacting
residues are shown with side chains. The hydro-
philic interactions are indicated with dotted lines
and the residues involved in two hydrophobic
interaction surfaces are boxed by solid lines as
that in (A).
(C) Sequence alignment of several representative
Rab GTPases. The switch and interswitch regions,
the CDRs, and the hypervariable region are indi-
cated. The region observed in the Rab9A-RUTBC2
RBD structure is indicated using two horizontal
bars. The residues involved in interactions with
RUTBC2 RBD are indicated with triangles, with the
conserved residues colored in black and the vari-
able one in blue.
(D) Electrostatic surface representations of Rab9A
and RUTBC2 RBD. The hydrophobic and hydro-
philic patches at the interface are circled with solid
and dotted lines, respectively. The surfaces of
Rab9A and RUTBC2 RBD at the interaction inter-
face show both geometrical and electrostatic
complementarities.
Structure
Structural Basis of the Rab9A-RUTBC2 Interaction
1412 Structure 22, 1408–1420, October 7, 2014 ª2014 Elsevier Ltd All rights reserved
Figure 3. Mutational Analyses of the Rab9A-RUTBC2 RBD Interaction
(A) Upper panel: in vitro GST pull-down assays between the wild-type (Q66L) and mutant GST-Rab9A and the wild-type His6-RUTBC2 RBD. Lower panel: in vitro
GST pull-down assays between the wild-type (Q66L) GST-Rab9A and the wild-type and mutant His6-RUTBC2 RBD. The gels were stained by Coomassie blue.
(B) Isothermal titration calorimetry (ITC) analyses of the binding affinities between the wild-type (Q66L) and mutant His6-Rab9A and the wild-type and mutant
His6-RUTBC2 RBD. Rab9A mutants are labeled in blue and RUTBC2 RBD mutants in green. The dissociation constant (Kd) is indicated.
(C) Confocal fluorescence microscopy images of HeLa cells coexpressing GFP-Rab9A and Myc-RUTBC2 or their mutants. Scale bar represents 10 mm.
See also Figure S2.
Structure
Structural Basis of the Rab9A-RUTBC2 InteractionBoth Rab9A and Rab9B Can Bind to RUTBC2 and
the Hypervariable Region Is Not Required for
RUTBC2 Binding
It was shown previously that RUTBC1 and RUTBC2 can interact
with both Rab9A and Rab9B based on the yeast two-hybrid
screening analyses; however, they can only bind Rab9A basedStructure 22, 1408–on the in vitro GST pull-down assays (Nottingham et al., 2011,
2012). As Rab9A and Rab9B are highly diverged in the C-termi-
nal hypervariable region, Nottingham et al. (2011, 2012) sug-
gested that RUTBC1 and RUTBC2 might recognize part of
the hypervariable region of Rab9A to distinguish from Rab9B.
In the Rab9A-RUTBC2 RBD structure, Rab9A interacts with1420, October 7, 2014 ª2014 Elsevier Ltd All rights reserved 1413
Table 2. ITC Measured Thermodynamic Parameters between
Rab9A (Q66L) and RUTBC2 RBD in Both Wild-Type and Mutant
Forms and the Parameters between Different Rab9 Variants and
RUTBC2 RBD
Kd (mM) DH (kcal/mol)
TDS
(kcal/mol) n Value
Rab9A Mutants
WT 0.32 ± 0.08 4.57 ± 0.10 4.29 0.88 ± 0.01
F37A 1.09 ± 0.19 3.28 ± 0.07 4.71 0.73 ± 0.01
I40A 26.7 ± 5.4 2.98 ± 0.52 3.16 0.41 ± 0.05
G41A ND ND ND ND
G41D ND ND ND ND
V42A 10.5 ± 3.6 1.69 ± 0.24 4.99 0.68 ± 0.07
E43A 72.5 ± 16.5 18.4 ± 4.7 12.8 0.42 ± 0.10
F44A 32.0 ± 7.6 5.21 ± 1.15 0.81 0.51 ± 0.09
W61A 30.8 ± 5.9 7.66 ± 1.05 1.61 0.61 ± 0.06
R68A 2.60 ± 0.60 3.52 ± 0.15 3.98 0.80 ± 0.02
F76A 12.7 ± 2.3 6.84 ± 0.42 0.28 0.77 ± 0.03
RUTBC2 RBD Mutants
WT 0.32 ± 0.08 4.57 ± 0.10 4.29 0.88 ± 0.01
L256A 45.0 ± 13.0 4.17 ± 0.94 1.76 0.89 ± 0.13
K260A 23.6 ± 9.5 2.53 ± 0.52 3.79 1.10 ± 0.14
N261A ND ND ND ND
N262A 0.85 ± 0.23 2.92 ± 0.08 5.37 1.13 ± 0.02
Y277A ND ND ND ND
N294A ND ND ND ND
M297A 25.4 ± 5.4 4.46 ± 0.41 1.82 1.08 ± 0.06
Q361A 1.41 ± 0.30 4.52 ± 0.11 3.46 1.06 ± 0.02
Rab9 Variants
Rab9A 0.32 ± 0.08 4.57 ± 0.10 4.29 0.88 ± 0.01
Rab9ADC 0.39 ± 0.07 4.86 ± 0.08 3.88 1.03 ± 0.01
Rab9B 0.33 ± 0.07 5.49 ± 0.14 3.34 0.62 ± 0.01
Rab9BDC 0.79 ± 0.18 4.64 ± 0.11 3.70 0.73 ± 0.01
Rab9A-GDP 40.0 ± 8.3 4.02 ± 0.59 1.98 0.83 ± 0.08
Rab9A 1-201 0.77 ± 0.10 4.69 ± 0.05 3.67 0.93 ± 0.01
ND, not detected.
See also Figures S2 and S3.
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Structural Basis of the Rab9A-RUTBC2 InteractionRUTBC2 RBD only through the switch and interswitch regions,
and the C-terminal hypervariable region is disordered and thus
is not required for the binding of RUTBC2 RBD (Figure 1B).
Sequence comparison shows that the residues of Rab9A
involved in the interactions with RUTBC2 RBD are strictly
conserved in Rab9B (Figure 2C). Structural comparison also
shows that the switch and interswitch regions in the GppNHp-
bound Rab9B assume almost identical conformations as those
in the GppNHp-bound Rab9A and the Rab9A-RUTBC2 RBD
complex (rmsd of <1.00 A˚ for50 Ca atoms in the switch and in-
terswitch regions) (Figure 1D). These results suggest that the
C-terminal hypervariable region of Rab9A is unlikely involved in
the binding of RUTBC2 and Rab9B should be able to bind to
RUTBC2 in a similar way as Rab9A.
To verify those results, we analyzed the binding abilities
and affinities between RUTBC2 RBD and Rab9A/Rab9B
with (Rab9A/Rab9B, residues 1–199) or without (Rab9ADC/1414 Structure 22, 1408–1420, October 7, 2014 ª2014 Elsevier Ltd ARab9BDC, residues 1–171) the hypervariable region using
in vitro GST pull-down and ITC analyses. Our GST pull-down re-
sults show that RUTBC2 RBD can bind to Rab9A and Rab9B
with similar binding ability, and the presence or deletion of the
hypervariable region of Rab9A and Rab9B does not affect their
binding with RUTBC2 RBD (Figure 4A). In addition, our results
show that RUTBC1 RBD can also bind to Rab9A and Rab9B
with similar binding ability and property as RUTBC2 RBD (Fig-
ure 4A), consistent with the high sequence conservation of the
RBD of RUTBC1 and RUTBC2 (73% identity) (Figure S4A). Our
ITC results show that the Kd values of RUTBC2 RBD with
Rab9A and Rab9B are 0.32 ± 0.08 mM and 0.33 ± 0.07 mM,
respectively, and the Kd values of RUTBC2 RBD with Rab9ADC
and Rab9BDC are 0.39 ± 0.07 mM and 0.79 ± 0.18 mM, respec-
tively, consistent with our GST pull-down results (Figure 4B).
Moreover, to ensure that other regions of RUTBC2 do not affect
its binding with Rab9A/Rab9B, we analyzed the binding abilities
of the full-length RUTBC2 with Rab9A/Rab9B and Rab9ADC/
Rab9BDC by GST pull-down assays. Our results show that the
full-length RUTBC2 can bind to both Rab9A and Rab9B and
deletion of the C-terminal hypervariable region of Rab9A/
Rab9B has no significant effect on the binding (Figure S4B). Tak-
ing our structural and biochemical data together, we conclude
that both Rab9A and Rab9B can bind to RUTBC2 and the C-ter-
minal hypervariable region of Rab9A/Rab9B is not required for
RUTBC2 binding. Intriguingly, the previous biochemical data
showed that the hypervariable region of Rab9A/Rab9B is
required for the binding of some effectors such as Tip47 and
p40 (Aivazian et al., 2006). It is unclear whether Rab9A/Rab9B
could bind to these effectors in different way(s) from that to
RUTBC2. More thorough studies are needed to resolve this
issue.
Binding Specificity of Rab9A with RUTBC2
Previous biochemical data showed that RUTBC1/RUTBC2 can
bind to Rab9A/B but not other Rabs (Nottingham et al., 2011,
2012). Consistently, our ITC results also show that there is no
detectable interaction between RUTBC2 RBD and several repre-
sentative Rabs including the closely related Rab7A and the
distantly related Rab3A and Rab5A. Rabs usually use the switch
and interswitch regions to recognize and bind the effectors (Ea-
thiraj et al., 2005, 2006; Jagoe et al., 2006; Recacha et al., 2009;
Shiba et al., 2006; Zhu et al., 2004). In some Rab-effector com-
plexes, the CDRs of Rabs are also involved in determining the
binding specificity for the effectors (Chavas et al., 2008; Kuki-
moto-Niino et al., 2008; Ostermeier and Brunger, 1999; Wu
et al., 2005). In the structure of the Rab9A-RUTBC2 RBD com-
plex, the binding site of Rab9A for RUTBC2 RBD is only
composed of residues of the switch and interswitch regions.
The major structural determinants of Rab9A for binding RUTBC2
RBD consist of the hydrophobic triad of three strictly conserved
aromatic residues (Phe44, Trp61, and Phe76) of the switch and
interswitch regions, several less conserved hydrophobic resi-
dues of the switch I/II regions, and the conserved ‘‘IGVEF’’ motif
of switch I (Figures 2A and 2B). Sequence alignment indicates
that the residues of Rab9A involved in the interactions with
RUTBC2 RBD are highly conserved among all Rabs (Figure 2C).
An obvious question is why RUTBC2 RBD can specifically bind
to Rab9A but not other Rabs.ll rights reserved
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Structural Basis of the Rab9A-RUTBC2 InteractionDetailed structural comparisons of the Rab9A-RUTBC2 RBD
complex with several representative Rab-effector complexes
including the Rab3A-Rabphilin-3A complex, the Rab5A-
Rabaptin-5 complex, and the Rab7A-RILP complex, reveal
some subtle but important conformational differences in the
switch and interswitch regions between Rab9A and the other
Rabs even though their overall structures are very similar (Fig-
ure 5). First, the conserved ‘‘IGVEF’’ motif of switch I in Rab9A
assumes an outward conformation compared with the other
Rabs so that the side chain of Glu43 and the main-chain amino
or/and carbonyl groups of Ile40, Gly41, and Val42 can form
extensive hydrogen bonds with RUTBC2 RBD. Second, the
N terminus of the b2 strand in the interswitch region of
Rab9A is one residue shorter than that in the other Rabs and
this shortening appears to provide some conformational flexi-
bility for the ‘‘IGVEF’’ motif of switch I to interact with RUTBC2
RBD. Third, the a2 helix formed by switch II in Rab9A is posi-
tioned closer to the switch I and interswitch regions than that
in the other Rabs and thus the switch and interswitch regions
can form the specific hydrophobic patches to bind RUTBC2
RBD. These results lead us to suggest that like in some
Rab-effector complexes (Eathiraj et al., 2005; Merithew et al.,
2001), the conformational plasticity of the switch and inter-
switch regions of Rab9A is the major determinant for the bind-
ing specificity with RUTBC2. Nevertheless, it should be noted
that the subtle sequence differences in and around the switch
and interswitch regions might affect the conformations of these
regions and thus could also contribute in part to the binding
specificity of Rab9A with RUTBC2 RBD. As Rab9B can also
bind to RUTBC2 and Rab9B and Rab9A are highly conserved
in both sequence and structure, we predict that Rab9B may
bind to RUTBC2 RBD in a similar manner as Rab9A. Addition-
ally, as the sequences of the RBD of RUTBC1/RUTBC2 are
also highly conserved among different species (>50% similar-
ity) and most of the residues participating in the Rab9A binding
are strictly conserved (Figure S4A), we also predict that
RUTBC1 may bind to Rab9A/Rab9B in a similar manner as
RUTBC2.
DISCUSSION
So far, many Rab9 effectors have been identified; however, no
structure of any Rab9-effector complex has been reported.
The crystal structure of the Rab9A-RUTBC2 RBD complex
together with our biochemical data reveals the molecular basis
for the binding specificity of Rab9A with RUTBC2. Specifically,
we show that the C-terminal hypervariable region of Rab9A is
not required for RUTBC2 binding and the conformational plas-
ticity of the switch and interswitch regions of Rab9A primarily de-
termines the specificity for RUTBC2. In addition, our structural
and biochemical data suggest that Rab9A/Rab9B may bind to
RUTBC1/RUTBC2 in a similar manner. These findings can help
us understand the biological functions of the PH domain contain-
ing proteins and the binding specificity of RabGTPaseswith their
effectors.
RUTBC2 RBD assumes a PH domain fold and functions as the
effector of Rab9. PH domain is one of the most common do-
mains in human genome and many PH domain-containing pro-
teins are involved in cellular signaling, cytoskeletal organization,Structure 22, 1408–transcription, DNA repair, membrane trafficking, and phospho-
lipid medication (Lemmon, 2004, 2007; Scheffzek and Welti,
2012). Some PH domains can bind specifically to phosphoinosi-
tides (PIs) with high affinities to target cellular membranes. How-
ever, most of the PH domains bind to PIs with only low or no
affinities and are not membrane targeted or confined to partic-
ular cellular compartments; they can serve as protein-protein in-
teracting platforms to bind to a variety of proteins and to execute
diverse functions. For examples, some PH domains can serve as
effectors of small GTPases and some others can bind to GEFs of
small GTPases to regulate the GEF activities (Scheffzek and
Welti, 2012).
For those PH domains that can bind to PIs with high affinities
and specificities, a positively charged surface groove composed
mainly of several basic residues can specifically bind distinct PIs
(Lemmon, 2004, 2007; Scheffzek andWelti, 2012). For instances,
DAPP1 uses the surface groove between the b1-b2 loop and the
b3-b4 loop to bind phosphatidylinositol-(3,4,5)-triphosphate
(PI(3,4,5)P3) and PI(3,4)P2 (Ferguson et al., 2000); and b-spectrin
uses another surface groove between the b1-b2 loop and the b5-
b6 loop to bind PI(4,5)P2 (Hyvo¨nen et al., 1995) (Figure 6).
Sequence comparison shows that there are no basic residues
in the corresponding regions of RUTBC2 RBD (Figure S1C),
consistent with the surface electrostatic analysis result showing
that there is no obvious positively charged surface groove on
RUTBC2 RBD (Figure 6). Moreover, no detectable binding of
RUTBC2 RBD with some common PIs was observed using a
highly sensitive lipid-overlay blot (data not shown). These results
indicate that RUTBC2 RBD may not bind to PIs.
Although PH domains can act as effectors of small GTPases,
the Rab9A-RUTBC2 RBD complex is the first structure of a PH
domain effector complexed with a RabGTPase (Figure 1). Struc-
tural analyses of the available small GTPase-PH domain com-
plexes show that PH domains can bind to small GTPases using
distinct binding sites or surfaces (Figure S5). In some cases,
such as the RalA-Exo84 complex (Jin et al., 2005), the Rac2-
PLC-g2 complex (Bunney et al., 2009), the RhoA-PRG complex
(Chen et al., 2010), and the Arf1-ARHGAP21 complex (Me´ne´trey
et al., 2007), the PH domains interact with small GTPases mainly
through the b5-b7 sheet and the following a1 helix. In other
cases, such as the Arf6-Grp1 complex (Malaby et al., 2013),
the Ran-RanBD1 complex (Vetter et al., 1999), and the Rac1-
PLC-b2 complex (Jezyk et al., 2006), the PH domains interact
with small GTPasesmainly via the b1-b4 sheet and the peripheral
regions. In the Rab9A-RUTBC2 RBD complex, the binding site of
RUTBC2 RBD for Rab9A involves mainly the b1 strand and the
h1 insertion, which is similar to that of RanBD1 and PLC-b2 for
their respective small GTPases (Figure S5). Nevertheless, Ran
and Rac1 lay along the b2 strand of the PH domain, while
Rab9A packs against the b1 strand of the PH domain. It is also
noteworthy that based on the binding features of the effectors
with Rab and Arf GTPases, the binding modes are divided into
‘‘all a-helical,’’ ‘‘mixed a-helical, ‘‘b-b zipping,’’ and ‘‘bivalent’’
modes (Khan and Me´ne´trey, 2013). However, the binding of
RUTBC2 RBD with Rab9A involves mainly the b1 strand and
the h1 insertion that is different from these observed in the other
Rab-effector complexes, and thus we refer to this binding mode
as a ‘‘mixed a/b’’ mode that also includes the Rab5-EEA1 com-
plex (Mishra et al., 2010) (Figure S6).1420, October 7, 2014 ª2014 Elsevier Ltd All rights reserved 1415
Figure 4. Analyses of the Interactions between Rab9A/Rab9B and RUTBC1/RUTBC2 RBD
(A) In vitro GST pull-down analyses of Rab9A/Rab9B with RUTBC1/RUTBC2 RBD. GST-RUTBC1/RUTBC2 RBDwere preloaded onto the glutathione Sepharose
beads and then incubated with His6-Rab9A/Rab9B at 4
C for 2 hr. After washing three times with the lysis buffer, the beads were analyzed by western blotting
(legend continued on next page)
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Figure 5. Structural Comparison of Repre-
sentative Rabs in Complexes with their
Effectors
Superpositions of Rab9A-RUTBC2 RBD with
Rab3A-Rabphilin-3A (PDB code 1ZBD) (Os-
termeier and Brunger, 1999), Rab5A-Rabaptin-5
(PDB code 1TU3) (Zhu et al., 2004), and Rab7A-
RILP (PDB code 1YHN) (Wu et al., 2005) are shown
in three panels, respectively, with Rab9A colored
in yellow and the other Rabs in gray. The sec-
ondary structures are indicated.
Structure
Structural Basis of the Rab9A-RUTBC2 InteractionThe previous biochemical data showed that RUTBC2 can bind
to Rap1/Rap2 using the so-called RAPID motif (residues 301-
350) (Yang et al., 2007). This region also lies in the RBD of
RUTBC2 and comprises mainly the b4-b6 strands (Figures 1B,
1C, and S4A). Structurally, the Rab9A and Rap binding sites
have no overlap with each other, and thus RUTBC2 RBD could
bind with Rab9A and Rap simultaneously. Given that Rab9
mainly controls the recycling of MPRs from late endosomes to
the TGN (Pfeffer, 2009), while Rap mainly regulates the polarity
and differentiation of neuronal cells, synaptic plasticity, cell-cell
adhesion, and actin dynamics (Frische and Zwartkruis, 2010),
and RUTBC1/RUTBC2 are expressed in many types of cells
but are enriched in neuronal cells (Yang et al., 2007), the simulta-
neous binding of RUTBC1/RUTBC2 with Rab9 and Rap might
mediate the crosstalk of the two signaling pathways in the devel-
opment of neuronal cells. In addition, as the RUN domains could
function as the effectors of some Rap and Rab GTPases (Calle-
baut et al., 2001), and the TBC domains of RUTBC1 and
RUTBC2 have specific GAP activity for Rab32/Rab33B and
Rab34/Rab36, respectively, all of which are involved in regu-
lating the biogenesis of lysosome-related organelles (Notting-
ham et al., 2012), it is possible that RUTBC1/RUTBC2 might
interact with these small GTPases to function synergistically in
their sequential activation and inactivation to ensure the direc-
tionality of membrane transport events or bridge the crosstalk
of different signaling pathways in broad cellular processes.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of Proteins
Rab9A and RUTBC2 RBD were amplified by PCR from the cDNA library of
mouse brain cells and cloned into the pET-22b plasmid (Novagen) that at-
taches a C-terminal His6 tag and the pET-28a plasmid (Novagen) that at-
taches an N-terminal His6 tag, respectively. The mutants were constructed
using the QuikChange Site-Directed Mutagenesis kit (Strategene). The re-
combinant proteins were expressed in Escherichia coli BL21 (DE3) Codon-
Plus strain (Novagen). The transformed cells were grown at 37C in LB
medium containing 0.05 mg/ml ampicillin or kanamycin until OD600 reached
0.8 and then induced with 0.25 mM IPTG at 16C for 24 hr. The harvested
cells were lysed by sonication in a lysis buffer (20 mM Tris-HCl, pH 8.0,using anti-GST and anti-His antibodies. GST was used as control. Rab9A/Rab9
Rab9ADC/Rab9BDC: Rab9A/Rab9B with the C-terminal hypervariable region de
(B) ITC analyses of the binding affinities between Rab9A/Rab9B and RUTBC2 R
See also Figures S3 and S4.
Structure 22, 1408–1 mM MgCl2, 150 mM NaCl, and 1 mM PMSF) and the cell lysates were
centrifuged at 40,000 3 g for 40 min. Rab9A and RUTBC2 RBD were purified
separately by affinity chromatography using a Ni-NTA column (QIAGEN) in the
lysis buffer. To get the Rab9A-RUTBC2 complex, the two proteins were
mixed at 1:1 molar ratio in the lysis buffer and incubated with 1 mM GTP at
4C overnight followed by gel filtration chromatography using a Superdex
200 16/60 column (GE Healthcare) in a storage buffer (20 mM Tris-HCl, pH
8.0, 1 mM MgCl2, and 150 mM NaCl). The resultant sample was of >95% pu-
rity as evaluated by SDS-PAGE.
In Vitro GST Pull-Down Assay
Our biochemical studies show that the full-length Rab9A/Rab9B (residues 1–
201) is partially dimerized in solution probably due to formation of a disulfide
bond between the two cysteines at the C terminus (Figure S3). The partial
dimerization of the full-length Rab9A/Rab9B could make their amounts bound
to RUTBC2 RBD in more than 1:1 molar ratio in the GST pull-down assay
although it does not affect the binding with RUTBC2 RBD. Thus, to avoid
possible artifact in the GST pull-down assay, we used the C-terminal cysteine
truncated Rab9A/9B (residues 1–199) to analyze their binding abilities with
RUTBC2 RBD.
For the mutational analyses of the Rab9A-RUTBC2 RBD interaction, Rab9A
Q66L (residues 1–199) was cloned into the pGEX 4T-1 plasmid (GEHealthcare)
to attach a GST tag at the N terminus, and RUTBC2 RBD (residues 254–425)
was cloned as above to attach a His6 tag at the N terminus. The recombinant
proteins were expressed as above. His6-RUTBC2RBDwas purified by Ni-NTA
affinity chromatography in the lysis buffer. GST-Rab9A was purified by GST
affinity chromatography on glutathione-coated Sepharose beads (GE Health-
care) in the lysis buffer, as recommended by the manufacturer. Twenty micro-
grams (or 0.4 nmol) of GST-Rab9A were immobilized onto the glutathione
Sepharose beads and then incubated with 100 mg (or 5 nmol) of His6-RUTBC2
at 4C for 2 hr in 1ml lysis buffer supplemented with 1mMGTP and 1mMDTT.
The beads were washed three times (10 min each) with the same buffer and
then analyzed by SDS-PAGE with Coomassie blue staining. GST was used
as control.
For the binding analyses of Rab9A/Rab9B with RUTBC1/RUTBC2, Rab9A/
Rab9B Q66L with (Rab9A/Rab9B, residues 1-199) or without the C-terminal
hypervariable region (Rab9ADC/Rab9BDC, residues 1–171) were cloned into
the pET-22b plasmid to attach a His6 tag at the C terminus, and full-length
RUTBC2 (residues 1–1,093), RUTBC2 RBD (residues 254–425), and RUTBC1
RBD (residues 242–424) were cloned into the pGEX 4T-1 plasmid to attach a
GST tag at the N terminus. The recombinant proteins were expressed and pu-
rified as above. GST-RUTBC1/RUTBC2were immobilized onto the glutathione
Sepharose beads and then incubated with His6-Rab9A/Rab9B. The beads
were analyzed by western blotting using anti-GST and anti-His antibodies.B: Rab9A/Rab9B with the C-terminal two cysteines deleted (residues 1–199);
leted (residues 1–171).
BD. The dissociation constant (Kd) is indicated.
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Figure 6. Comparison of the Electrostatic
Surfaces of RUTBC2 RBD with DAPP1 and
b-Spectrin
The three PH domain proteins are shown in the
same orientation with IPs in stick models. In the
DAPP1-IP4 structure (PDB code 1FAO), IP4 is
bound in a positively charged pocket between the
b1–b2 loop and the b3–b4 loop of the PH domain
(Ferguson et al., 2000). In the b-spectrin-IP3 struc-
ture (PDB code 1BTN), IP3 is bound in a positively
charged pocket between the b1–b2 loop and the
b5–b6 loop (Hyvo¨nen et al., 1995). In the RUTBC2
RBD structure, the equivalent binding sites of IP4
and IP3 in the above two complexes are indicated
based on superposition of the three structures.
Structure
Structural Basis of the Rab9A-RUTBC2 InteractionIsothermal Titration Calorimetry Analysis
Isothermal titration calorimetry (ITC) measurements were performed at 25C
using an ITC200 Micro-calorimeter (MicroCal). An initial injection of 0.8 ml pro-
tein sample was discarded for each data set in order to remove the effect of
titrant diffusion across the syringe tip during the equilibration process. For
Rab9A/Rab9B (wild-type, mutants, and variants), each experiment consisted
of 20 injections of 2 ml RUTBC2 RBD (1 mM) into the sample cell containing
250 ml different Rab9 (100 mM). For RUTBC2 RBD (wild-type and mutants),
the same experiments were performed with injections of 2 ml Rab9 (1 mM)
into 250 ml different RUTBC2 RBD (100 mM). All the proteins were expressed
and purified as described above and kept in the storage buffer. A background
titration was performed using identical titrant with the buffer solution placed in
the sample cell. Titration curveswere fit by a nonlinear least-squaresmethod in
MicroCal Origin software version 7.0 using the single site binding model.
Immunofluorescence Microscopy Analysis
Immunofluorescence microscopy analysis was performed to analyze the co-
localization of Rab9A and RUTBC2. GFP-Rab9A (residues 1–201) was cloned
into the pEGFP-C3 vector (Clontech) and Myc-RUTBC2 (residues 1–1,093)
into the pcDNA3 vector (Invitrogen). HeLa cells were cultured on coverslips
in DMEM (Hyclone) supplemented with 10% fetal bovine serum (Biochrom),
pretreated with 10 mg/ml poly-D-Lys (Sigma) for 18 hr, and then transiently
transfected with the plasmids using Lipofectamine 2000 (Invitrogen). Thirty-
two hours after transfection, the cells were fixed with 4% paraformaldehyde
at 25C for 15 min. Then the cells were permeabilized with 0.1% Triton X-
100 in PBS for 10min and incubated sequentially with rabbit anti-Myc antibody
and the secondary antibody. The coverslips were then mounted on glass
slides and the confocal images were obtained using a Leica TCS SP5 confocal
microscope with a 633 oil immersion lens.
Crystallization, Diffraction Data Collection, and Structure
Determination
Crystallization was performed using the hanging drop vapor diffusion method
at 16C by mixing equal volumes (1.0 ml) of protein solution (20 mg/ml) and
reservoir solution. Crystals of the Rab9A-RUTBC2 complex were grown
from drops containing the reservoir solution of 0.2 M ammonium acetate,
0.1 M sodium acetate (pH 5.0), and 20% (w/v) polyethylene glycol 4,000.
The crystals were cryoprotected with paratone and flash-frozen in liquid nitro-
gen. Diffraction datawere collected at175Cat BL17U of Shanghai Synchro-
tron Radiation Facility and processed with HKL2000 (Otwinowski and Minor,
1997).
Structure of the Rab9A-RUTBC2 RBD complex was solved with the molec-
ular replacement (MR) method as implemented in Phenix (Adams et al., 2010)
using the GppNHp-bound Rab9A structure (Protein Data Bank [PDB] code
1YZL) (Eathiraj et al., 2005) as the search model. In the MR-phased electron
density map, the structure of Rab9A was well defined, and additionally there
was evident and continuous electron density for several b strands correspond-
ing to the b1–b4 strands of RUTBC2 RBD. Iterative cycles of manual model
building of a partial polyalanine model of RUTBC2 RBD and real-space refine-
ment gradually developed more electron density that allowed us to build the
full structure model of RUTBC2 RBD. Structure refinement was carried out us-
ing Phenix (Adams et al., 2010) and Refmac5 (Murshudov et al., 1997), and1418 Structure 22, 1408–1420, October 7, 2014 ª2014 Elsevier Ltd Amodel building using Coot (Emsley and Cowtan, 2004). Stereochemistry of
the structure model was analyzed using Procheck (Laskowski et al., 1993).
Structural analyses were carried out using programs in CCP4 (Winn et al.,
2011) and the PISA server (Krissinel and Henrick, 2007). Structure figures
were generated using PyMOL (http://www.pymol.org). The statistics of the
structure refinement and final structure model are summarized in Table 1.
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